Details
Stereochemistry | ACHIRAL |
Molecular Formula | C5H4N2O2 |
Molecular Weight | 124.0975 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(=O)C1=NC=CN=C1
InChI
InChIKey=NIPZZXUFJPQHNH-UHFFFAOYSA-N
InChI=1S/C5H4N2O2/c8-5(9)4-3-6-1-2-7-4/h1-3H,(H,8,9)
Molecular Formula | C5H4N2O2 |
Molecular Weight | 124.0975 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Substituted pyrazinecarboxamides: synthesis and biological evaluation. | 2006 Mar 29 |
|
Substituted N-phenylpyrazine-2-carboxamides, their synthesis and evaluation as herbicides and abiotic elicitors. | 2007 Dec 20 |
|
Structural determination of hypnosin, a spore germination inhibitor of phytopathogenic Streptomyces sp. causing root tumor in melon (Cucumis sp.). | 2007 Dec 26 |
|
2'-(3-Hydroxy-benzyl-idene)pyrazine-2-carbohydrazide monohydrate. | 2007 Dec 6 |
|
Dibromidobis(pyrazine-2-carboxylic acid-κN)mercury(II) dihydrate. | 2007 Dec 6 |
|
Magnetic properties and molecular structures of binuclear (2-pyrazinecarboxylate)-bridged complexes containing Re(IV) and M(II) (M = Co, Ni). | 2007 Jan 21 |
|
Discovery of pyrazine carboxamide CB1 antagonists: the introduction of a hydroxyl group improves the pharmaceutical properties and in vivo efficacy of the series. | 2007 Jul 15 |
|
Mechanistic implications of the active species involved in the oxidation of hydrocarbons by iron complexes of pyrazine-2-carboxylic acid. | 2008 Apr 21 |
|
Characterization of Mycobacterium tuberculosis nicotinamidase/pyrazinamidase. | 2008 Feb |
|
Interpretation of the multiple vanadium-oxygen bonds in the central VO(eta2-O2)+ group. Synthesis, structure, supramolecular interactions and DFT studies for complexes with 2,2'-bipyridine, 1,10-phenanthroline, pyrazinato(1-) and pyrazinamide ligands. | 2008 Jan 7 |
|
Medical management of genitourinary tuberculosis. | 2008 Jul |
|
4-Carboxy-pyridazin-1-ium chloride. | 2008 Jul 19 |
|
Silymarin protects liver against toxic effects of anti-tuberculosis drugs in experimental animals. | 2008 Jul 5 |
|
Identification of a new urate and high affinity nicotinate transporter, hOAT10 (SLC22A13). | 2008 Jun 13 |
|
Diaqua-bis(pyrazine-2-carboxyl-ato-κN,O)manganese(II) dihydrate. | 2008 Mar 14 |
|
Vibrational spectroscopic studies and ab initio calculations of a substituted amide of pyrazine-2-carboxylic acid--C12H10ClN3O. | 2008 Nov 15 |
|
Metal and mixed-metal coordination polymers synthesized with pyrazine-2-carboxylate. | 2008 Nov 21 |
|
Suppression of blood lipid concentrations by volatile Maillard reaction products. | 2008 Nov-Dec |
|
Plasma urate level is directly regulated by a voltage-driven urate efflux transporter URATv1 (SLC2A9) in humans. | 2008 Oct 3 |
|
Synthesis and structures of a new series of silver-vanadate hybrid solids and their optical and photocatalytic properties. | 2008 Sep 15 |
|
Poly[diaqua(μ(2)-oxalato-κO,O:O,O)(μ(2)-pyrazine-2-carboxyl-ato-κN,O:O')cerium(III)]. | 2008 Sep 20 |
|
Protective effects of coffee-derived compounds on lipopolysaccharide/D-galactosamine induced acute liver injury in rats. | 2009 Apr |
|
Interpreting expression data with metabolic flux models: predicting Mycobacterium tuberculosis mycolic acid production. | 2009 Aug |
|
Poly[diaqua-(μ(2)-oxalato-κO,O:O,O)(μ(2)-pyrazine-2-carboxyl-ato-κN,O:O,O')neodymium(III)]. | 2009 Aug 12 |
|
Poly[bis-(μ(2)-pyrazine-2-carboxyl-ato)-κN,O:O';κN,O:O-cadmium(II)]. | 2009 Dec 24 |
|
What lies behind serum urate concentration? Insights from genetic and genomic studies. | 2009 Dec 29 |
|
Ligand-based modification of the structures and optical properties of new silver(I)-rhenate(VII) oxide/organic hybrid solids. | 2009 Dec 7 |
|
Poly[hexa-aqua-bis(μ(3)-terephthalato)(μ(2)-terephthalato)diytterbium(III)]. | 2009 Dec 9 |
|
Genome-wide analysis of the PreA/PreB (QseB/QseC) regulon of Salmonella enterica serovar Typhimurium. | 2009 Feb 23 |
|
Derivatives of pyrazinecarboxylic acid: 1H, 13C and 15N NMR spectroscopic investigations. | 2009 Jul |
|
Lipophilic pyrazinoic acid amide and ester prodrugs stability, activation and activity against M. tuberculosis. | 2009 Jun 28 |
|
The identification of orally bioavailable thrombopoietin agonists. | 2009 Mar 1 |
|
A polymorph of diaqua-bis(pyrazine-2-carboxyl-ato-κN,O)copper(II). | 2009 Nov 4 |
|
Tetra-ethyl-ammonium tricarbonyl-chlorido-(pyrazine-2-carboxyl-ato-N,O)rhenate(I). | 2009 Oct 17 |
|
Substituted N-Phenylpyrazine-2-carboxamides: synthesis and antimycobacterial evaluation. | 2009 Oct 20 |
|
Combined Mössbauer spectral and density functional theory determination of the magnetic easy-axis in two high-spin iron(II) 2-pyrazinecarboxylate complexes. | 2009 Sep 7 |
|
Mutations found in the pncA gene of Mycobacterium tuberculosis in clinical pyrazinamide-resistant isolates from a local region of China. | 2009 Sep-Oct |
|
Epidemiology of gout. | 2010 |
|
Poly[aqua-(μ-pyrazine-2-carboxyl-ato-κN,O:O)(μ-pyrazine-2-carboxyl-ato-κN,O:O')lead(II)]. | 2010 Apr 17 |
|
Photoluminescent lanthanide-organic bilayer networks with 2,3-pyrazinedicarboxylate and oxalate. | 2010 Apr 5 |
|
Synthesis and anti-mycobacterial evaluation of some pyrazine-2-carboxylic acid hydrazide derivatives. | 2010 Aug |
|
Surveillance of pyrazinamide susceptibility among multidrug-resistant Mycobacterium tuberculosis isolates from Siriraj Hospital, Thailand. | 2010 Aug 20 |
|
A series of transition metal-azido extended complexes with various anionic and neutral co-ligands: synthesis, structure and their distinct magnetic behavior. | 2010 Aug 28 |
|
Antimicrobial Susceptibility Testing of Mycobacterium bovis Isolates from Michigan White-Tailed Deer during the 2009 Hunting Season. | 2010 Dec 2 |
|
Poly[di-μ-aqua-μ(4)-(pyrazine-2,5-dicarboxyl-ato)-dilithium(I)]. | 2010 Dec 8 |
|
QSAR modeling of a set of pyrazinoate esters as antituberculosis prodrugs. | 2010 Feb |
|
Xanthine oxidase inhibition by allopurinol increases in vitro pyrazinamide-induced hepatotoxicity in HepG2 cells. | 2010 Jul |
|
Peruvian and globally reported amino acid substitutions on the Mycobacterium tuberculosis pyrazinamidase suggest a conserved pattern of mutations associated to pyrazinamide resistance. | 2010 Mar |
|
The near future: improving the activity of rifamycins and pyrazinamide. | 2010 May |
|
Reductive degradation of pyrazine-2-carboxylate by a newly isolated Stenotrophomonas sp. HCU1. | 2010 Sep |
Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:56:00 GMT 2025
by
admin
on
Mon Mar 31 19:56:00 GMT 2025
|
Record UNII |
2WB23298SP
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
1585017
Created by
admin on Mon Mar 31 19:56:00 GMT 2025 , Edited by admin on Mon Mar 31 19:56:00 GMT 2025
|
PRIMARY | |||
|
202-718-1
Created by
admin on Mon Mar 31 19:56:00 GMT 2025 , Edited by admin on Mon Mar 31 19:56:00 GMT 2025
|
PRIMARY | |||
|
71311
Created by
admin on Mon Mar 31 19:56:00 GMT 2025 , Edited by admin on Mon Mar 31 19:56:00 GMT 2025
|
PRIMARY | |||
|
98-97-5
Created by
admin on Mon Mar 31 19:56:00 GMT 2025 , Edited by admin on Mon Mar 31 19:56:00 GMT 2025
|
PRIMARY | |||
|
13146
Created by
admin on Mon Mar 31 19:56:00 GMT 2025 , Edited by admin on Mon Mar 31 19:56:00 GMT 2025
|
PRIMARY | |||
|
DTXSID30243367
Created by
admin on Mon Mar 31 19:56:00 GMT 2025 , Edited by admin on Mon Mar 31 19:56:00 GMT 2025
|
PRIMARY | |||
|
C005296
Created by
admin on Mon Mar 31 19:56:00 GMT 2025 , Edited by admin on Mon Mar 31 19:56:00 GMT 2025
|
PRIMARY | |||
|
m9340
Created by
admin on Mon Mar 31 19:56:00 GMT 2025 , Edited by admin on Mon Mar 31 19:56:00 GMT 2025
|
PRIMARY | Merck Index | ||
|
1047
Created by
admin on Mon Mar 31 19:56:00 GMT 2025 , Edited by admin on Mon Mar 31 19:56:00 GMT 2025
|
PRIMARY | |||
|
PYRAZINOIC ACID
Created by
admin on Mon Mar 31 19:56:00 GMT 2025 , Edited by admin on Mon Mar 31 19:56:00 GMT 2025
|
PRIMARY | |||
|
2WB23298SP
Created by
admin on Mon Mar 31 19:56:00 GMT 2025 , Edited by admin on Mon Mar 31 19:56:00 GMT 2025
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> METABOLITE | |||
|
PARENT -> METABOLITE |